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Summary  
 
“Between 6.29 million and 6.57 million people in South Africa are estimated to be 
HIV positive” (Quinn, 7/11/2005) The primary issue pertaining to HIV/AIDS, is 
the control of the spread of the infection. A critical intervention strategy entails the 
effective management of sexually transmitted infections, which could reduce the 
HIV incidence by 40% according to Mayhew,S. et. al, 2001.  
 
Factors  such as; stigma,  limited resources, inaccessibility to affordable and effective 
drugs etc, impact on the management of STIs. In view of the significant 
consequences of inadequate STI management, there is growing international 
support for STI prevention and control. It is clear that decreasing the rate of STI  
infection will impact positively on reducing the spread of HIV  and AIDS. 
 
Numerous epidemiological and biological studies now support the fact that STIs, 
enhance HIV transmission (Wasserheit JN, 1992). Those infected with HIV become 
more infective, due to the STI related inflammatory conditions. The more frequent 
the episodes of STI in a HIV positive individual, the faster the progression to full-
blown AIDS. 
 
This dissertation therefore, endorses the current strategy by the State involving the 
syndromic approach in the management of STIs. This approach is a treatment option 
based on the identification of a constellation of symptoms and signs experienced by 
the patient. The focus of this paper is a proposal for inclusion of pharmacists as 
essential role-players in this programme of action. Considering the significant role 
of the pharmaceutical industry in drug management, it is incomprehensible that the 
Government’s strategic plan currently excludes pharmacists. Pharmacists, generally, 
are perceived as trusted health care professionals with extensive knowledge on 
health care issues. Thus training pharmacists in the syndromic approach will 
certainly contribute to effective control of the infection. Issues such as adherence 
counselling will have a better prognosis due to the specialized knowledge of the 
pharmacist; and follow-up, if required, will be easily accessible to the patient. 
Further, the patient will be able to report any side effects, seek change to treatment 
and discuss any concerns almost immediately with the pharmacist.  
 
 
 
 
 
 
 
  
  
 
The benefit will be seen in the possible decrease in the number of new infections, 
due both to the professional counselling intervention, and early detection. In view of 
the aforementioned, this paper proposes a review of legislation as well as the 
Government’s strategic plan for STI management. It goes further to suggest a best 
practice model for the involvement of pharmacists in the programme of action to 
reduce the spread of STIs,  and subsequently, HIV and AIDS. It projects a vision of a 
new professional role for pharmacy in the context of public/private partnerships in 
health delivery programmes. The rigorous tertiary training of pharmacists certainly 
suggests that their role surpasses the arena of drug delivery management and must 
therefore not be the only focus of their professional role. They must be seen as an 
essential part of the health care team with the freedom and endorsement to use the 
other professional skills with which they’re equipped, to provide more 
comprehensive patient care.  
 
 
 
 
 
 
 
 
 
 
  
  
Opsomming 
 
Dit is welbekend dat die familie-apteker normaalweg baie nou saamwerk met sy 
kliënte, naamlik die publiek.  Net soos in die geval van die rol by die handhawing 
van goeie gesondheid, kan die apteker na alle waarskynlikheid ook ‘n beduidende 
rol vervul by pasiëntesorg in die geval van MIV/Vigs. 
 
Hierdie studie ondersoek die rol van die apteker in gesondheidsorg van die 
Vigspasient.  Die resultaat van die studie is ‘n voorstel vir ‘n beste-praktyk model vir 
aptekers in die stryd teen MIV/Vigs. 
 
Daar word voorgestel dat die Departement van Gesondheid en die 
Aptekersvereniging van Suid-Afrika hierdie voorstel ter tafel neem. 
 
 
 
 
 
 
 
 
 
 
  
  
1. Linking Sexually Transmitted Infections and 
HIV/AIDS 
 
Between 6.29 million and 6.57 million people in South Africa are estimated to be 
HIV positive (Quinn, 7/11/2005). The critical issue in relation to HIV/AIDS is the 
control of the spread of the infection and the provision of support services to those 
already infected (medical, financial, psychological etc.).  Although sexually 
transmitted infections (STIs) have been causing significant morbidity and mortality 
for years, it is only with the advent of HIV, that STI control is now receiving higher 
priority in both developed and developing countries. This is because STIs increase 
the transmission of HIV and have similar behavioural risk factors. (Family Health 
International, 2002) One of the key areas of control of HIV transmission therefore, 
is the effective management of sexually transmitted infections (STI’s) which could 
reduce the HIV incidence by 40% (Mayhew,S. et. al, 2001).  
 
The syndromic management of STIs is a treatment option based on a constellation of 
symptoms and signs experienced by the patient. Diagnosis requires no laboratory 
facilities and patients are able to obtain treatment at the time of their visit. Patients 
are not lost in follow-up and this contributes to the prevention of sequelae and 
further transmission. All major pathogens are treated.  
 
STI control is now receiving higher priority in both developed and developing 
countries due to the presence of HIV although STIs have been causing morbidity and 
mortality for years. This is because STIs increase the potential and risk of 
transmission of HIV and are associated with a similar repertoire of behavioural risk 
factors. As many as 333 million new curable STIs occur globally each year (WHO 
1995). It is also predicted that STIs have the potential for serious economic, social 
and health consequences particularly in view of their clear and indisputable link to 
HIV, yet all STIs are preventable and many are curable. It is therefore critical that 
every available resource is utilised in the prevention and control of STIs. The 
dynamic effect of STI prevention or cure is illustrated by the following: by curing or 
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preventing 100 cases of syphilis amongst an STI high risk group, approximately 109 
new HIV infections and 4132 new syphilis cases could be prevented in the next ten 
years (Over M, 1993).  
 
In many developing countries, the health care systems are already strained by 
having to deal with other health problems related to poverty, malnutrition and the 
lack of running water and sanitation. Provision of health care and diagnostic 
facilities is clearly inadequate in these countries this invariably impacts on the 
management of sexually transmitted infections. The stigma associated with STI’s, the 
limited resources, and the lack of affordable and effective drugs exacerbate the 
situation.  In view of the significance of the consequences of inadequate STI 
management, the cause poses a worthy focus for national level efforts given the 
growing literary and global support for, and awareness of, the importance of STI 
prevention and control. Indeed, if progress can be made in decreasing the rate of 
infection, a significant decrease in HIV infections, maternal and infant morbidity, 
and mortality will inevitably follow. 
 
Numerous epidemiological and biological studies now support the fact that STIs, 
both ulcerative and non-ulcerative, enhance HIV transmission (Wasserheit JN, 
1992). Those infected with HIV become more infective, due to the STI related 
inflammatory conditions. The more episodes of STI in a HIV positive individual 
expedite the progress to full-blown AIDS.  In a recent community based, 
randomised trial in the Mwanza district of rural Tanzania, it was demonstrated that, 
treating STI-symptomatic individuals using the syndromic approach reduced HIV 
incidence in the study population by 42 percent (Grosskurth H, 1995). STIs have 
been ranked amongst the top 5 categories for which adults in developing countries 
seek health care services.  
 
The high incidence and prevalence of sexually transmitted infections (STIs) in 
Southern Africa poses a serious threat to public health for two main reasons. First, 
the impact of these infections is a major cause of healthy life lost, particularly for 
women and children, and secondly, because STIs are important co-factors in driving 
the HIV epidemic (Colvin M). In developing countries, poverty both promotes the 
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transmission of STIs and diminishes the capacity of a nation to mount effective anti-
STI programmes. Work-related migrants in Southern Africa contribute to the spread 
of STIs, including HIV, because individuals are at relatively high risk of having 
multiple and concurrent sexual relations. Women migrants and those left behind in 
the rural areas are often forced into 'survival sex', whereby sex is exchanged for 
favours. Those infected individuals who do seek treatment frequently delay before 
doing so and when treatment is obtained it may not be appropriate.  These 
programmes should ensure access to effective and acceptable STI services, 
expanding public education and targeting STI interventions at high-risk and core 
transmitter groups. In the longer term, cheaper and effective diagnostic tests are 
needed that will permit large-scale screening to reduce the burden of asymptomatic 
STIs. Home test kits may be a possible solution. 
Individuals with STIs are particularly prone to HIV infection and AIDS because: 
• Sexual intercourse with an infected partner is by far the main mode of 
transmission of STIs as well as HIV and AIDS infection. (WHO 2001) 
• Individuals with STIs that cause genital ulcers (sores) are especially 
susceptible to infection with the HI virus as the ulcers provide an easy way 
into the body through openings in the mucous membranes  
• STIs that do not cause ulcers also facilitate the transmission of HIV because 
any genital inflammation speeds up the migration of certain HIV-sensitive 
and receptive cells (lymphocytes such as CD4 cells) to the site where the HI 
virus can attach itself and be carried further into the body  
• Genital discharges and secretions are common symptoms of STIs and often 
the site of high concentrations of the HI virus  
• A person infected with the HI virus who also has an STI is extremely 
infectious and, if the person has multiple partners, he or she will infect 
others.  
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2. Current STI strategies in South Africa 
 
There is compelling evidence regarding the importance of STIs as a major 
determinant of HIV transmission in South Africa. Approximately 11 million STI 
episodes are treated annually with approximately 5 million of these managed by the 
private general practitioner (HIV/AIDS/STI Strategic Plan for South Africa 2000-
2005)(Feb 2000). Clearly, even without the HIV pandemic STIs as a health issue 
pose an important public health problem.  These figures represent only those 
seeking treatment options.  
 
Thus, in the countries strategic plan, (referred to above), the second goal in the 
priority area of prevention, addresses the issue of management and control of STI’s. 
The Government’s strategic plan in the area of prevention appears, at first glance, to 
be inclusive in that it places great emphasis on both the private and public sector in 
terms of effective use of the syndromic approach. However, while key health 
workers in both the private and public sector have been targeted, including doctors, 
nurses, the traditional healers; the pharmacist, pharmacy organisations and their 
professional council have been completely excluded from this plan. Considering the 
significant role of the pharmaceutical industry in drug management from 
manufacturing to the ultimate act of counselling and dispensing, this represents a 
significant and incomprehensible omission. Ironically, Government has elected to 
grant dispensing licences to nurses at considerable training costs to the state, for STI 
management but failed to utilise the existing resource of more than two and a half 
thousand existing dispensing licenses that are located in community pharmacy 
which represents a resource pool of 4000 pharmacists and almost double that 
number of pharmacist assistants.  
 
The Department of Health in its strategic plan has identified “adequate human 
resources” as key to delivery of the plan, more significant even than the issue of 
funding. In keeping with this strategic focus, the NDOH has access to a large pool of 
health care workers within pharmacy that require minimal additional training to be 
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part of this human resource requirement. It is likely that while the plan did not 
focus particularly on the strategic role of the pharmacist, the Role of Sectors (Section 
7.2) makes reference to each sector developing specific plans based on their ‘role in 
society, activities and their specific strengths’. This document therefore, attempts to 
highlight the significant role of community pharmacy and the need to for the 
community pharmacy industry to mobilize its resources and document a possible 
‘Best Practice’ so as to demonstrate its vital role in addressing the problem of  
effective STI and HIV management.   
 
A detailed review of the strategic plan for STI management by the Department of 
Health highlights the absence of the pharmacist as part of the health care team. It is 
hoped that the next review due to take place soon will take full cognisance of the 
motivation and include some of the suggestions made. Below is an extract from the 
National Department of Health Strategic Plan for STI Management (2000) 
(Highlighted in grey are suggestions by the writer for inclusion in future 
documents) 
 
Improve the Management and Control of STI’s 
 
Objective Basic Strategies Lead Agencies 
 
Ensure effective 
Syndromic  
Management of STI’s in  
The private sector 
 
 
 
 
 
 
 
 
 
 
a. Investigate granting 
Dispensing licences to nurses 
for STI treatment 
b. Monitor and regulate the 
quality of care in the private 
sector 
c. Training on syndromic 
management in the private 
sector 
d. Review Medical Schemes 
regulations to ensure 
minimum reimbursement for 
treating STI. 
e. Review regulations to allow 
pharmacist to dispense STI 
treatment. 
  
 
DOH, SAMA 
BHF, HPCSA, Organised Pharmacy 
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Ensure effective  
Syndromic Management of STI’s in the public 
sector 
a. Training in syndromic 
management 
undergraduate/basic curricula 
of nurses, doctors, pharmacist 
b. Regular in-service training of 
HCW,s 
DOH, SANC, Nurses training inst. 
Medical school. Pharmacy Schools 
 
Collaborate with traditional healers to improve 
health care seeking behaviour for STI treatment 
 
a. Develop, print and distribute 
training manuals in various 
languages. 
b. Conduct capacity building 
workshops with TH’s and 
Pharmacies 
c. Sensitise the health sector 
regarding traditional medicine 
d. Consider referral systems 
between traditional and 
western medicine. 
 
 
DOH, Traditional Healer Org,  
CONTRALESA 
Pharmacies 
 
Increase access to youth friendly reproductive 
health services- including STI management, 
VCT and Rapid HIV testing facilities (special 
focus on youth, women, and migrant workers) 
 
 
 
a. Make clinics and HCW’s 
“youth friendly”. 
b. Make schools places where 
youth access friendly 
counselling services. 
c. Setup counselling centres in 
pharmacies 
 
DOH, DOE, Youth Sector 
Pharmacies 
 
 
 
 
 
 
While cost effective treatment protocols are available in the state health services the 
incidence of STI’s in South Africa, as in most parts of Sub-Saharan Africa, is 
unacceptably high (WHO 1995). This may be related to a host of well known and 
well researched factors that contribute to the non-utilisation of state health services 
(overcrowding, waiting time, inability to get leave from work, transport and other 
related costs, attitude of service provider, etc). 
Since 1994 in South Africa, there's been a massive shift from racially-biased, 
doctor-centred, hospital-based curative care, towards easily-accessible primary 
health care. According to Helen Schneider, head of the Wits Centre for Health 
Policy, the Government has failed miserably to demonstrate effective management of 
sexually transmitted infections (STIs), "While public sector hospitals and clinics are 
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following the correct diagnostic and treatment protocols, efforts are being 
undermined by private sector GPs and district surgeons who have appalling rates in 
treating the infections," she says. Thus, training protocols are of critical value for all 
sectors to our health care industry. 
HIV and AIDS experts agree that health care professionals need to remain cognisant 
of the deadly association between HIV and other STIs. Individuals with STIs may 
already be infected with the HI virus and vice versa. A holistic treatment 
programme, which includes educating individuals about the dangers of STIs and 
HIV infection and presents sufferers with measures to prevent the spread of both 
diseases, should form part of the treatment programme. 
Research shows that many GPs have never heard of the World Health Organisation 
guidelines on the subject, and in some categories of STIs, only four percent of 
private patients receive effective treatment. "As GP services are driven by profit, 
patients received only the treatment that they could afford to pay for and in most 
cases this was ineffective," says Schneider. 
 
The District STI Quality of Care Assessment (DISCA) tool was used by the NDOH to 
evaluate the quality of STI services in South Africa. In 18 months, the percentage of 
clinics providing correct syndromic treatment for STIs increased to 86%,  and the 
number of partner contact slips that were handed out increased from 156 to 1 122. 
This was as a result of the states education intervention which indicates that similar 
success can be achieved with the correct intervention in many other areas. In the 
case of pharmacy the states objectives can be achieved with the entire programme 
being managed within this sector, with minimum intervention by the State. It will be 
in the interest of this profession to facilitate this intervention and to bear the cost of 
training. A similar type of programme saw thousands of general practitioners 
upgrade their skills over a very short period to meet the requirement for the issuing 
of the dispensing licences.    
 
For any STI programme to succeed it requires a high focus on educational efforts to 
reduce risk, condom availability, case finding through partner tracing and effective 
antenatal screening. The synergy of efforts in this direction promises to be a more 
effective approach to STI control and demands that more attention be directed 
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towards socio-behavioural aspects of STIs. The approach directs consideration of the 
STI policy environment as well as a more consumer or patient-oriented approach to 
health service delivery. Once a community is educated and motivated to seek 
treatment for STIs, there is more pressure on clinical services to meet its demands. If 
clinical services are more efficacious and user-friendly, it is more likely that the 
community will use them. 
 
The level of accessibility and acceptability of services to a community, are important 
determinants of whether those who know they may be infected will actually seek 
care. Factors that detract from acceptability of services include high user fees, long 
waiting lines, lack of privacy, lack of empathy and acceptance by the health 
provider, and lack of access to effective drugs (Schultz KF 1987). 
 
The Strategic priorities for the NDOH indicate that the syndromic approach to STI 
has been implemented in all public facilities with every facility having at least one 
trained health worker. Government has attempted to extend this training to the 
private sector but recognises that more effort is required especially with private 
general practitioners. The effort, it seems, is not well coordinated and structured to 
have any meaningful impact.  
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3. Review of the role of pharmacist in syndromic 
management of STIs on the international front 
 
A recent study by the UK's Nuffield Institute of Health and the London School of 
Hygiene and Tropical Medicine together with the Ghanaian Health Ministry suggest 
that pharmacists represent an under-utilised resource for STI and HIV prevention 
activities.  Interviews with pharmacists and patients in the Greater Accra Region 
revealed that each pharmacist sees an average of 30 STI patients per month. This 
translates to one STI patient per day adding up to almost 1 million cases per year in 
South African terms. In the above study   more than 60% arrive without a 
prescription. Research suggests that proper treatment of sexually transmitted 
infections (STIs) could reduce HIV incidence by as much as 40% (Mayhew,S. et. al, 
2001).  
 
Pharmacists in the above study were placed in a training scheme and the study 
found a marked improvement in prescribing patterns for the simple urethral 
discharge.  A study in Cameroon in the early 1990's indicated that 50% of male 
patients with a history of acute urethritis in the previous 12 months decided not to 
seek care in the formal health sector (Louis JP 1993).  
 
There is increasing evidence that a large proportion of STI patients seek care 
elsewhere, such as from traditional healers, pharmacists, friends, or in the 
marketplace. Thus training pharmacists in the syndromic approach and allowing 
for marketing of STI treatment packages will certainly contribute to effective control 
of the infection. 
 
In a study by the University of the Western Cape (K.L. Ward et. al.) it was 
determined that a large majority of pharmacist (74.1%) viewed their role in STI 
management as under utilised. There was a major indication of pharmacists’ 
willingness to provide syndromic STI treatment (50.6 strong, and 47.1% slight). On 
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the other hand the quality of STI treatment amongst community pharmacists was 
poor (13.6% prescribing correct treatment for penile discharge, 6.3% for genital 
ulcers and 0% for vaginal discharge). While this study clearly underlines the need 
for STI treatment services in community pharmacies, there is a strong motivation for 
a training intervention and a best practice protocol for pharmacists.   
 
Data from Mwanza, Tanzania, and Nairobi, Kenya, show that making available 
accessible and affordable care including effective drugs can cause a shift in health-
care-seeking behaviour within the official medical services.     
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4. Role of pharmacist in current strategies of STI 
management and obstacles to full participation. 
 
Pharmacists in South Africa are not able to effectively manage sexually transmitted 
infections (STI) because the law prevents the pharmacist from dispensing the 
necessary drugs without a prescription. There has been a belief in the industry that 
pharmacist could play a crucial role in effective STI management if they were 
sanctioned to dispense the drugs used in the syndromic approach to STI 
management.. 
 
Community pharmacy is ideally placed to interact as a first point of treatment if 
given the opportunity. The inability of the community to seek treatment from 
pharmacy with current legislation barriers influences the behaviour of community 
members. Perceived high cost related to the private GP, waiting period in accessing 
the public sector and the negative association of public health currently, may 
prevent the patient from seeking treatment timeously. This would impact 
significantly on the spread of infection in view of the fact that, the longer the 
infection remains untreated, the more opportunities there are for transmission to 
occur.   
 
The perceived lack of treatment options at community pharmacy may even prevent 
patients from accessing advice or preventative measures at the pharmacy level. This 
undoubtedly affects the opportunity to intervene as soon as possible. 
 
Pharmacists in most communities are perceived as trusted health care professionals 
with extensive knowledge on health care issues. They are easily accessible and 
always available and their services are perceived as ‘no cost’ or ‘low cost’ especially 
with primary health care matters. With the stigma related to most sexually 
transmitted infections, the first point of contact must be provided with minimum 
barriers. If communities are made aware that they are able to collect medication for 
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these types of infection at their local pharmacy, the response time in seeking 
treatment post infection may be drastically reduced due to these minimized barriers. 
Unlike any other point of entry the adherence counselling will be extensive due to 
the specialized knowledge of the pharmacist on the drugs; and the follow-up, if 
required, will be easily accessible to the patient. Added to this, the patient will be 
able to report any side effects, seek change to treatment and discuss any concerns 
almost immediately with the pharmacist.  
 
If the community pharmacist is seen as an additional entry point for STI treatment, 
those patients that need to be referred will first be counselled. The benefit will be 
seen in the possible decrease in the number of new infections, due to both the 
counselling intervention, and early detection.      
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5. A proposed Best Practice Approach 
 
Understanding the characteristics of STIs commonly associated with 
HIV infection 
In rural and less developed areas the identification and diagnosis of STIs (prior to 
treatment) is based on a checklist of symptoms associated with the following five 
categories of STI infection: 
1. STIs characterised by a discharge from the penis or female urethra or cervix 
(not vagina) such as gonorrhoea and chlamydia (non-gonococcal urethritis) 
as well as rectal gonococcal infection (in homosexual males). It is also 
associated with gonococcal pharyngitis, a throat infection, linked to oral sex 
and candidiasis (thrush) in both men and women  
2. STIs characterised by a discharge from the vagina such as trichomoniasis, 
that may also cause vaginitis (vaginal inflammation) and cystitis (bladder 
infection), genital candidiasis (thrush) and bacterial vaginosis (non-specific 
vaginitis)  
3. STIs caused by syphilis, genital herpes and chancroid, characterised by 
genital ulcers or sores on the penis and in the anal/rectal region in 
homosexual males or on the labia, vulva, vaginal walls or cervix in women. 
Chancres are painless ulcers or soft sores that develop on the genitals while 
chancroid causes infection and ulceration of the lymph nodes in the groin  
4. STIs characterised by a genital discharge as well as a genital ulcer or sore  
5. STIs characterised by severe, lower abdominal pain such as acute pelvic 
inflammatory disease (PID). PID may and is often caused by gonorrhoea 
Training Requirements for pharmacists 
Diagnosis and treatment of STIs by pharmacists may form the backbone of a key 
initiative in the long term management of this infection. It opens the door for more 
role players to be involved in the fight against this disease and in the fight against 
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HIV/AIDS. It allows for easy entry of patients with fewer obstacles into an 
environment where changes in sexual behaviour can be encouraged, positive 
intervention in other risk-reduction strategies can be initiated with appropriate 
treatment of sexual partners. While Counselling and education, Condom promotion, 
Compliance to treatment/adherence counselling and Contact tracing of partners 
(referred to as the 4Cs) are critical components of a good STI management 
programme, the reality we face, is that patients only enter the system at the point 
when diagnosis and treatment is required.  This then is the point of interception, a 
point where pharmacists are strategically placed to catch the flow. 
Critical components of the training module must involve:  
1. Identification and classification of the type of sexually transmitted infection. 
A diagnostic questionnaire needs to be designed to be used as a guideline by 
pharmacists in the identification/preliminary diagnostic process that will 
exclude physical examination of patient  
2. Defining those infections which can be treated using the syndromic 
management approach and clearly defining those that must be referred. 
(clinic, doctor, hospital). 
3. Equipping pharmacists with upgraded counselling skills and techniques 
needed to interact with a patient. This will include addressing attitudes, 
teaching skills such as listening, warmth, empathy and genuineness, using 
questioning techniques appropriately, verbal and non-verbal skills, guiding 
patients about how to help and protect themselves n respect of precautions 
necessary during infection, partner referral/tracing and condom use.   
4. Review of drugs and their combinations needed for maximum effectiveness 
to treat the infections. This will include dosages, side effects, contra-
indications, drug resistance, and most importantly adherence counselling.  
5. Designing a follow up procedure for patients 
6.  Review of general education principles in STI management. 
7. Customising existing algorithms for South African pharmacists to follow 
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Key elements of counselling of patients: 
 
1. Nature of the infection: This must include its transmission mode. 
2. Potential complications.  
3. Partner treatment 
4. Adherence to treatment 
5. Abstinence/safe sex during infection 
6. Prevention 
7. HIV testing 
8. Use of contact tracing and referral slips 
9. Educational aids 
10. Questions to determine diagnosis 
11. Flow charts 
12. Treatment guidelines with dosages 
 
The training for STI management must be adapted to the pharmacy setting and 
clinical experiences of the pharmacist. The programme needs to factor in the 
perceptions, attitudes and current behaviour of the provider and the patients 
considering that this is a new avenue. The programme must be able to create and 
sustain an enabling environment especially the provision of antibiotics for 
treatment. Critical to its success is a system of continuous evaluation of the 
effectiveness and outcome of treatment options, follow-up procedure, and referral 
programmes. The programme must also be able to measure and evaluate the extent 
of counselling intervention and the partner treatment and its impact on new 
infections.  
Effective STI management 
It has been found that unsuccessful STI control is as a result of unavailable or poor 
clinic services, inadequately trained providers, unavailability of drugs, cost of 
treatment, incorrect or inappropriate usage of drugs when accessed in the absence 
of counselling and proper professional guidelines.  
In 2002 the Health Systems Trust reported that at least 50% of professional nurses 
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surveyed in South Africa had some level of training in syndromic management of 
STIs. Almost all clinics in South Africa (94%) offered a STI service every week day 
(2003). Only 41% of the facilities surveyed (most senior nurse) was able to correctly 
outline the recommended drug treatment for the 3 common STI syndromes, i.e. 
vaginal discharge, urethral discharge and genital ulcers.  
Another area of concern is that 13% of the PHC facilities in SA (2003) reported 
having at least one of the five drugs considered essential for STI management, out of 
stock. In some provinces such as Eastern Cape and Limpopo these figures reached 
24% in the month of the survey.  
Requirements for Effective STI management include: 
1. Patients must be educated and informed so that they could tell if they were 
infected. 
2. Good services and drugs must be available and accessible to all. 
3. The creation of an environment to enable patients to access care promptly. 
4. Appropriate diagnostic tools and procedures to ensure accurate diagnoses. 
5. Education on proper and appropriate usage of drugs. 
6. Patient education about behaviour and lifestyle change pre, during and post 
infection 
7. Instruction about sexual activity during treatment must be followed. 
8. Protocols to facilitate partner tracing and referral. 
9. Easy accessibility and availability of Health Care providers to facilitate 
patient/partner follow-up. 
Pharmacists are well positioned to implement all of the above with minimal 
additional training.  
Most training interventions cover the three approaches to STI diagnosis: 
(EngenderHealth 2004) 
 
The clinical approach is considered the least reliable of the three. Using this 
approach, the health provider relies on his or her own experiences to arrive at a 
diagnosis based on the symptoms reported by the client and clinical signs observed 
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during the physical examination. This can be problematic because 
 STIs vary in appearance upon examination 
 More than one infection may be present making clinical diagnosis more 
difficult 
 Previous self-treatment or intervention by other providers may alter the 
appearance of signs and symptoms 
 
The etiological approach is the most traditional and accurate of the three. It is based 
on the results of laboratory tests. However, this resource is not always available to 
health workers in third world settings. It requires trained technicians, availability of 
lab supplies, and sometimes expensive and specialised equipment. 
 
The syndromic approach is often the most appropriate, particularly for poorly-
resourced settings. The approach allows for diagnosis on the basis of appropriate 
history-taking and identification of syndromes or combinations of signs and 
symptoms that are reported by the patient. The recommended  treatments  are 
effective for all the diseases that could cause the identified syndromes (American 
Sexually Transmitted Disease Assoc) However, syndromic management cannot 
address the widespread problem of asymptomatic infections .This is an area that 
should be targeted in training .Pharmacists must be able to identify these patients 
from minor complaints and refer for appropriate etiological tests.   
 
The World Health Organisation’s classification of the syndromic management 
consists of four key elements: 
1. Classification of the syndrome by its causal pathogens 
There are four main syndromes in this classification, urethral discharge in men, 
lower abdominal pain in women, vaginal discharge in women and genital ulcers 
in both men and women. This type of approach can only be used in patients 
with these distinct signs and symptoms. 
 
 
 
 
 
  17
 
 
  
  
Table:             Using the Syndromic Approach 
 Syndrome Possible STI 
Men Urethral discharge Chlamydia, Gonorrhoea 
Women Lower Abdominal 
Pain 
Vaginal discharge 
Chlamydia, Gonorrhoea, Other 
bacteria 
Chlamydia, Gonorrhoea 
Bacterial vaginosis, candidasis, 
Trichomonas infection. 
Men or 
Women 
Genital Ulcers Chancroid, Genital herpes, 
Syphilis 
 
2. Using flow charts (algorithms) to guide the management of the syndrome 
 
Flow charts have been designed to help the service provider determine which 
treatment to prescribe when using the syndromic approach. Each of these flow 
charts must be included in the training design so that the treatment protocol can be 
standardized. The flow charts in many instances are modified depending on what 
the common infection prevalence is for that particular area. 
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Vesicular lesions 
present or history 
of vesicular 
lesions, often 
recurrent 
Genital Ulcers 
YES 
Herpes 
Management 
NO 
Treat for syphilis and chancroid 
Treat Partner 
Education and counselling 
Follow-up after 7 days 
Improvement YES Clinical cure 
NO 
Refer 
3. Using an appropriate combination of drugs to deal with all the pathogens 
i.e. treatment and counselling. 
 
As this method treats all possible infections rather than single infection as in the 
etiological or clinical approach, the focus is largely on education and counselling. 
The pharmacist is in a position to help patients:  
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¾ understand and complete their treatment 
¾ see the importance of condom usage in these instances 
¾ change risk behaviour  
¾ trace and assist partners.  
 
STI Single-dose therapy 
 
Syphilis 
 
Benzathine Penicillin 
 
Chancroid 
 
Azithromycin or ceftriaxone 
 
Gonorrhea 
 
Cefixime, ceftriaxone, 
Ciprofloxacin or spectinomycin 
 
Chlamydia 
 
Azithromycin Doxycycline 
 
Trichomonas viginalis 
 
Metronidazole 
 
4. Partner treatment. 
If patients are effectively counselled and are able to understand the importance of 
breaking the cycle of infection it may be easier to convince them to refer their 
partners for treatment. Even those with no symptoms must be encouraged to seek 
treatment. Partner notification may be easier in the pharmacy setting as they may be 
located conveniently within the pharmacy patient profile.  
 
There is substantial evidence that the syndromic approach is easy to teach and learn, 
and that all levels of health care workers and facilities can use it. It does require an 
effective modular training approach with regular updates. In pharmacy this can be 
achieved with a short intensive classroom based module (weekends) and supported 
via updates through the various communication methods that already exists 
(internet, medical aids, computer vendors).  
The second advantage of immense importance in the South African context is the 
cost to patient. If one considers that, with an appropriate fee for pharmacist time, 
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medicines sourced via the State to the pharmacy would mean  
 
 little or no transport costs, as patients are located within communities served 
by community pharmacy 
 reduced waiting time 
 access to an after- hours service (so no need for time off from work) 
 no necessity for laboratory testing 
 
Thus savings will not only be related to the patient, but to the economy, the State 
and more importantly will impact on the HIV status of the nation.  The syndromic 
management ensures diagnosis and treatment within a single visit. Although 
patients are treated for mixed infection the use of flow charts can reduce the 
chances of inaccuracy or ineffective treatment.  
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6. A vision for the future 
 
This programme could map a new professional role in the context of 
public/private partnerships in health programmes. Pharmacists believe that the 
drug delivery management must not be the only focus of their activity. As part of a 
team they must be able to use the other professional skills for which they’ve been 
trained, to provide a more comprehensive patient care.  
 
In Policy issues for Ghana the task team, as far back as 2001, recommended that 
pharmacists are a valuable point of contact for STI patients and policy makers 
should ensure that all pharmacists receive training on national guidelines for 
syndromic management of STI’s. It was also recommended that pharmacists be 
encouraged to assist in prevention activities and that STI management be 
incorporated into pharmacy training curricula.   
 
Regulatory Changes 
De-scheduling  
 
 Allowing Pharmacists to dispense those combinations for the specific 
management of STI. 
 Removal of restrictive laws that prohibit diagnosis and treatment of STI’s 
by other health care professional such as nurses and pharmacists. 
 
Adapting: Developing the criteria needed to offer the service 
 
1. Record keeping system. 
2. The pharmacy will need a proper lockable filing system to store 
patient record cards. The card will contain patient history, 
diagnosis and treatment profile. Any side effects to medication or 
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referral may also be recorded.  
3. Private counselling area is essential. 
4. Pharmacist and assistants need to be trained in STI management. 
5. Ensure availability/stock of medication to treat STI. 
6. Proper systems for accountability of State dispensed medication. 
The pharmacy must be able to provide stock control and audits on 
a regular basis.  
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7. Conclusion 
 
It is envisaged that if the treatment protocol is made available in all South African 
private pharmacies (2600 country wide), at a minimum cost to patients, more 
individuals will utilise the service resulting in a substantial reduction in STI’s and 
thus a decrease in the spread of HIV/AIDS. The Government of Nepal has classified 
this as ‘filling a service delivery gap’ and believe that in resource constrained 
settings utilising the pharmacist to provide improved, simple curative care services 
in STI management benefits the community as provision of quality drugs and health 
education by a trusted health care professional is a sustainable best practice 
Pharmacists represent a valuable point of contact for STI patients. To capitalise on 
this, policymakers should: 
9 Ensure that all pharmacists receive training on the 
national guidelines for syndromic management of STIs 
 
9 Include a representative from pharmacy on the national 
strategic planning team 
 
9 Assess the array of skills embodied in a trained 
professional pharmacist for utilisation in the strategic 
plan rather than duplicate training and “re-invent the 
wheel” 
 
9 Assess the feasibility of utilising the infra-structure of 
community pharmacies ie physical location, professional 
skills, technical expertise, access to patients, patient 
data-bases and profiling, etc to maximise the impact of 
the strategic plan 
 
9 Encourage pharmacists to engage in preventative 
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activities such as promoting condom use ,displaying 
educational posters, and facilitating community 
workshops on prevention and safer sex practices 
 
9 Incorporate STI management into pharmacy training 
curricula 
 
9 Clearly define pharmacists’ roles in STI treatment 
including limitations and when to refer 
 
9 Share responsibility for controlling pharmacists’ 
activities between pharmacy regulating bodies and the 
Ministry of Health to avoid possible tensions and 
controversies 
 
Finally, the global burden of STIs and their effects are sobering. Although there are 
resource issues that are beyond the direct influence of providers and managers, it is 
possible to improve services in the areas that are still within their sphere of 
influence. Programme managers are in a position to advocate for interventions and 
resources that will result in STI prevention and prompt and effective treatment. 
Training pharmacists to provide syndromic management of STI treatment may be 
one such intervention that promises to make a difference. Managers must meet the 
challenges posed by STIs by co-ordinating private and public practices, 
strengthening supportive infrastructures and community linkages, and providing 
active and informed support for excellence in the clinical practice of all health 
workers at all levels. This issue is too important to allow for conscious or 
unconscious marginalisation of professionals who have a critical role to play. It is 
only through concerted, comprehensive efforts that strides will be made in 
preventing STIs and mitigating their effects with the ultimate objective of reducing 
STI morbidity and HIV transmission. 
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